The Roles of Mesenchymal Stem Cell-derived Exosomes in Diabetes Mellitus and Its Related Complications

Overview

Journal Front Endocrinol (Lausanne)

Specialty Endocrinology

Date 2022 Nov 7

PMID 36339446

Authors

Mengmeng Yang

Jun Chen

Li Chen

Affiliations

Soon will be listed here.

Abstract

Diabetes mellitus is a type of metabolic disease characterized by hyperglycemia, primarily caused by defects in insulin secretion, insulin action, or both. Long-term chronic hyperglycemia can lead to diabetes-related complications, causing damage, dysfunction, and failure of different organs. However, traditional insulin and oral drug therapy can only treat the symptoms but not delay the progressive failure of pancreatic beta cells or prevent the emergence of diabetic complications. Mesenchymal stem cells have received extensive attention due to their strong immunoregulatory functions and regeneration effects. Mesenchymal stem cell-derived exosomes (MSC-Exos) have been proposed as a novel treatment for diabetic patients as they have demonstrated superior efficiency to mesenchymal stem cells. This review summarizes the therapeutic effects, mechanisms, challenges, and future prospects of MSC-Exos in treating diabetes mellitus and its related complications. This review supports the potential use of MSC-Exos in future regenerative medicine to overcome the current difficulties in clinical treatment, particularly in treating diabetes.

Citing Articles

Applying adipose tissue-derived stem cell therapies as a novel treatment for atherosclerotic plaque development: Importance of appropriate dosing.

Allen M, Park S J Mol Cell Cardiol Plus. 2025; 10():100086.

PMID: 39801802 PMC: 11708246. DOI: 10.1016/j.jmccpl.2024.100086.

Stem Cell-Derived Exosomes: Natural Intercellular Messengers with Versatile Mechanisms for the Treatment of Diabetic Retinopathy.

Song Y, Yin C, Kong N Int J Nanomedicine. 2024; 19:10767-10784.

PMID: 39469447 PMC: 11514697. DOI: 10.2147/IJN.S475234.

Mesenchymal Stem Cell-Derived Exosomes Attenuate Hepatic Steatosis and Insulin Resistance in Diet-Induced Obese Mice by Activating the FGF21-Adiponectin Axis.

Kim B, Ronaldo R, Kweon B, Yoon S, Park Y, Baek J Int J Mol Sci. 2024; 25(19).

PMID: 39408777 PMC: 11476820. DOI: 10.3390/ijms251910447.

Therapeutic role of extracellular vesicles from human umbilical cord mesenchymal stem cells and their wide therapeutic implications in inflammatory bowel disease and other inflammatory disorder.

Azhar Ud Din M, Wan A, Chu Y, Zhou J, Yan Y, Xu Z Front Med (Lausanne). 2024; 11:1406547.

PMID: 39139783 PMC: 11319305. DOI: 10.3389/fmed.2024.1406547.

Stem Cell-Based Acellular Therapy: Insight into Biogenesis, Bioengineering and Therapeutic Applications of Exosomes.

Choudhery M, Arif T, Mahmood R, Harris D Biomolecules. 2024; 14(7).

PMID: 39062506 PMC: 11275160. DOI: 10.3390/biom14070792.

References

Wang Z, Xie Z, Lu Q, Chang C, Zhou Z . Beyond Genetics: What Causes Type 1 Diabetes. Clin Rev Allergy Immunol. 2016; 52(2):273-286. DOI: 10.1007/s12016-016-8592-1. View

Guillamat-Prats R . The Role of MSC in Wound Healing, Scarring and Regeneration. Cells. 2021; 10(7). PMC: 8305394. DOI: 10.3390/cells10071729. View

Lv Q, Deng J, Chen Y, Wang Y, Liu B, Liu J . Engineered Human Adipose Stem-Cell-Derived Exosomes Loaded with miR-21-5p to Promote Diabetic Cutaneous Wound Healing. Mol Pharm. 2020; 17(5):1723-1733. DOI: 10.1021/acs.molpharmaceut.0c00177. View

Yap S, Tan K, Abd Rahaman N, Hamid N, Ooi D, Tor Y . Human Umbilical Cord Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Ameliorated Insulin Resistance in Type 2 Diabetes Mellitus Rats. Pharmaceutics. 2022; 14(3). PMC: 8948940. DOI: 10.3390/pharmaceutics14030649. View

Wang C, Wang M, Xu T, Zhang X, Lin C, Gao W . Engineering Bioactive Self-Healing Antibacterial Exosomes Hydrogel for Promoting Chronic Diabetic Wound Healing and Complete Skin Regeneration. Theranostics. 2019; 9(1):65-76. PMC: 6332800. DOI: 10.7150/thno.29766. View

Donders R, Bogie J, Ravanidis S, Gervois P, Vanheusden M, Maree R . Human Wharton's Jelly-Derived Stem Cells Display a Distinct Immunomodulatory and Proregenerative Transcriptional Signature Compared to Bone Marrow-Derived Stem Cells. Stem Cells Dev. 2017; 27(2):65-84. DOI: 10.1089/scd.2017.0029. View

Nagaishi K, Mizue Y, Chikenji T, Otani M, Nakano M, Konari N . Mesenchymal stem cell therapy ameliorates diabetic nephropathy via the paracrine effect of renal trophic factors including exosomes. Sci Rep. 2016; 6:34842. PMC: 5056395. DOI: 10.1038/srep34842. View

Yu M, Liu W, Li J, Lu J, Lu H, Jia W . Exosomes derived from atorvastatin-pretreated MSC accelerate diabetic wound repair by enhancing angiogenesis via AKT/eNOS pathway. Stem Cell Res Ther. 2020; 11(1):350. PMC: 7425015. DOI: 10.1186/s13287-020-01824-2. View

Sato Y, Inoue M, Yoshizawa T, Yamagata K . Moderate hypoxia induces β-cell dysfunction with HIF-1-independent gene expression changes. PLoS One. 2014; 9(12):e114868. PMC: 4264765. DOI: 10.1371/journal.pone.0114868. View

10.

Casado-Diaz A, Quesada-Gomez J, Dorado G . Extracellular Vesicles Derived From Mesenchymal Stem Cells (MSC) in Regenerative Medicine: Applications in Skin Wound Healing. Front Bioeng Biotechnol. 2020; 8:146. PMC: 7062641. DOI: 10.3389/fbioe.2020.00146. View

11.

Zhang Y, Le X, Zheng S, Zhang K, He J, Liu M . MicroRNA-146a-5p-modified human umbilical cord mesenchymal stem cells enhance protection against diabetic nephropathy in rats through facilitating M2 macrophage polarization. Stem Cell Res Ther. 2022; 13(1):171. PMC: 9044847. DOI: 10.1186/s13287-022-02855-7. View

12.

Liang G, Qin Z, Luo Y, Yin J, Shi Z, Wei R . Exosomal microRNA-133b-3p from bone marrow mesenchymal stem cells inhibits angiogenesis and oxidative stress via FBN1 repression in diabetic retinopathy. Gene Ther. 2022; 29(12):710-719. DOI: 10.1038/s41434-021-00310-5. View

13.

Li W, Jin L, Cui Y, Nie A, Xie N, Liang G . Bone marrow mesenchymal stem cells-induced exosomal microRNA-486-3p protects against diabetic retinopathy through TLR4/NF-κB axis repression. J Endocrinol Invest. 2020; 44(6):1193-1207. DOI: 10.1007/s40618-020-01405-3. View

14.

Amable P, Teixeira M, Carias R, Granjeiro J, Borojevic R . Protein synthesis and secretion in human mesenchymal cells derived from bone marrow, adipose tissue and Wharton's jelly. Stem Cell Res Ther. 2014; 5(2):53. PMC: 4055160. DOI: 10.1186/scrt442. View

15.

Dionne K, Colton C, Yarmush M . Effect of hypoxia on insulin secretion by isolated rat and canine islets of Langerhans. Diabetes. 1993; 42(1):12-21. DOI: 10.2337/diab.42.1.12. View

16.

Xiang E, Han B, Zhang Q, Rao W, Wang Z, Chang C . Human umbilical cord-derived mesenchymal stem cells prevent the progression of early diabetic nephropathy through inhibiting inflammation and fibrosis. Stem Cell Res Ther. 2020; 11(1):336. PMC: 7397631. DOI: 10.1186/s13287-020-01852-y. View

17.

Toh W, Lai R, Zhang B, Lim S . MSC exosome works through a protein-based mechanism of action. Biochem Soc Trans. 2018; 46(4):843-853. PMC: 6103455. DOI: 10.1042/BST20180079. View

18.

Zheng Y, Ley S, Hu F . Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2017; 14(2):88-98. DOI: 10.1038/nrendo.2017.151. View

19.

Cao X, Xue L, Di Y, Li T, Tian Y, Song Y . MSC-derived exosomal lncRNA SNHG7 suppresses endothelial-mesenchymal transition and tube formation in diabetic retinopathy via miR-34a-5p/XBP1 axis. Life Sci. 2021; 272:119232. DOI: 10.1016/j.lfs.2021.119232. View

20.

Shabbir A, Cox A, Rodriguez-Menocal L, Salgado M, Van Badiavas E . Mesenchymal Stem Cell Exosomes Induce Proliferation and Migration of Normal and Chronic Wound Fibroblasts, and Enhance Angiogenesis In Vitro. Stem Cells Dev. 2015; 24(14):1635-47. PMC: 4499790. DOI: 10.1089/scd.2014.0316. View